Fluorescent regulators of RASSF1A expression and human cancer cell proliferation
US10457639B2 · kind B2 · utility
0Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2009 |
| Grant date | Oct 29, 2019 |
| Priority date | — |
| Expiry date | Aug 14, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for the treatment of cancer in a subject comprising administering a dansyl-carbazole compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.